Donald Poirier
Donald Poirier
Université Laval and CHU de Québec
Verified email at
Cited by
Cited by
Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer
ND Kim, R Mehta, W Yu, I Neeman, T Livney, A Amichay, D Poirier, ...
Breast cancer research and treatment 71 (3), 203-217, 2002
Inhibitors of 17‚-hydroxysteroid dehydrogenases
D Poirier
Current medicinal chemistry 10 (6), 453-477, 2003
Characteristics of human types 1, 2 and 3 17‚-hydroxysteroid dehydrogenase activities: oxidation/reduction and inhibition
V Luu-The, Y Zhang, D Poirier, F Labrie
The Journal of steroid biochemistry and molecular biology 55 (5), 581-587, 1995
Metal-based biologically active agents: Synthesis, characterization, antibacterial and antileukemia activity evaluation of Cu (II), V (IV) and Ni (II) complexes with antipyrine†…
T Rosu, M Negoiu, S Pasculescu, E Pahontu, D Poirier, A Gulea
European journal of medicinal chemistry 45 (2), 774-781, 2010
Comparison between hippocampus-synthesized and circulation-derived sex steroids in the hippocampus
Y Hojo, S Higo, H Ishii, Y Ooishi, H Mukai, G Murakami, T Kominami, ...
Endocrinology 150 (11), 5106-5112, 2009
Molecular therapy of breast cancer: progress and future directions
SX Lin, J Chen, M Mazumdar, D Poirier, C Wang, A Azzi, M Zhou
Nature Reviews Endocrinology 6 (9), 485-493, 2010
A concerted, rational design of type 1 17‚-hydroxysteroid dehydrogenase inhibitors: estradiol-adenosine hybrids with high affinity
W Qiu, RL Campbell, A Gangloff, P Dupuis, RP Boivin, MR Tremblay, ...
The FASEB Journal 16 (13), 1829-1831, 2002
17‚-Hydroxysteroid dehydrogenase inhibitors: a patent review
D Poirier
Expert opinion on therapeutic patents 20 (9), 1123-1145, 2010
Overview of a rational approach to design type I 17-hydroxysteroid dehydrogenase inhibitors without estrogenic activity: chemical synthesis and biological†…
MR Tremblay, D Poirier
The Journal of steroid biochemistry and molecular biology 66 (4), 179-191, 1998
Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells
R Poulin, D Baker, D Poirier, F Labrie
Breast cancer research and treatment 13 (2), 161-172, 1989
Synthesis and characterization of some new Cu (II), Ni (II) and Zn (II) complexes with salicylidene thiosemicarbazones: antibacterial, antifungal and in vitro antileukemia activity
E Pahontu, V Fala, A Gulea, D Poirier, V Tapcov, T Rosu
Molecules 18 (8), 8812-8836, 2013
Blockade of the stimulatory effect of estrogens, OH-tamoxifen, OH-toremifene, droloxifene, and raloxifene on alkaline phosphatase activity by the antiestrogen EM-800 in human†…
J Simard, R Sanchez, D Poirier, S Gauthier, SM Singh, Y Merand, ...
Cancer research 57 (16), 3494-3497, 1997
Multiple actions of synthetic °progestinsĘ on the growth of ZR-75-1 human breast cancer cells: Anin vitro model for the simultaneous assay of androgen, progestin†…
R Poulin, D Baker, D Poirier, F Labrie
Breast cancer research and treatment 17 (3), 197-210, 1991
Estradiol and estrone C-16 derivatives as inhibitors of type 1 17‚-hydroxysteroid dehydrogenase: Blocking of ER+ breast cancer cell proliferation induced by estrone
Y Laplante, C Cadot, MA Fournier, D Poirier
Bioorganic & medicinal chemistry 16 (4), 1849-1860, 2008
Antiestrogenic properties of keoxifene,trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells
R Poulin, Y Merand, D Poirier, C Levesque, JM Dufour, F Labrie
Breast cancer research and treatment 14 (1), 65-76, 1989
Potent Inhibition of Steroid Sulfatase Activity by 3-O-Sulfamate 17Š-Benzyl(or 4°-tert-butylbenzyl)estra-1,3,5(10)-trienes:  Combination of Two Substituents at†…
LC Ciobanu, RP Boivin, V Luu-The, F Labrie, D Poirier
Journal of medicinal chemistry 42 (12), 2280-2286, 1999
Steroid sulfatase inhibitors: a review covering the promising 2000–2010 decade
R Maltais, D Poirier
Steroids 76 (10), 929-948, 2011
Synthesis of simplified hybrid inhibitors of type 1 17‚-hydroxysteroid dehydrogenase via cross-metathesis and Sonogashira coupling reactions
M Bérubé, D Poirier
Organic letters 6 (18), 3127-3130, 2004
Synthesis and optimization of a new family of type 3 17‚-hydroxysteroid dehydrogenase inhibitors by parallel liquid-phase chemistry
R Maltais, V Luu-The, D Poirier
Journal of medicinal chemistry 45 (3), 640-653, 2002
Steroid sulfatase inhibitors
D Poirier, LC Ciobanu, R Maltais
Expert Opinion on Therapeutic Patents 9 (8), 1083-1099, 1999
The system can't perform the operation now. Try again later.
Articles 1–20